→
Cardinal Health Inc (CAH) demonstrates strong financial health with a market cap of $45.72B and a P/E ratio of 29.40, which is reasonable given its revenue growth of 12.88% year-over-year. The company has consistently beaten earnings estimates across the last four quarters, with Q3 2026 earnings at $3.17 per share compared to the estimate of $2.8157. With a solid ROE of 37.17% and an analyst consensus of 8 Strong Buy ratings, CAH is positioned for further upside.
Given the solid earnings performance and growth potential, I recommend a buy on CAH stock.
With a consistent track record of beating earnings estimates, including a 12.88% revenue growth year-over-year, Cardinal Health is in a solid position to capitalize on further market opportunities. The company's high ROE of 37.17% signals efficient management and strong profitability, which could attract more investors.
Despite solid earnings, Cardinal Health's current ratio of 0.91 raises concerns about its short-term liquidity, which could pose risks if unexpected liabilities arise. Additionally, the P/B ratio of 14.54 indicates that the stock may be overvalued relative to its book value, which could deter value-focused investors.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates CAH as Bullish. Given the solid earnings performance and growth potential, I recommend a buy on CAH stock.
Despite solid earnings, Cardinal Health's current ratio of 0.91 raises concerns about its short-term liquidity, which could pose risks if unexpected liabilities arise. Additionally, the P/B ratio of 14.54 indicates that the stock may be overvalued relative to its book value, which could deter value-focused investors.
With a consistent track record of beating earnings estimates, including a 12.88% revenue growth year-over-year, Cardinal Health is in a solid position to capitalize on further market opportunities. The company's high ROE of 37.17% signals efficient management and strong profitability, which could attract more investors.
Cardinal Health Inc (CAH) demonstrates strong financial health with a market cap of $45.72B and a P/E ratio of 29.40, which is reasonable given its revenue growth of 12.88% year-over-year. The company has consistently beaten earnings estimates across the last four quarters, with Q3 2026 earnings at $3.17 per share compared to the estimate of $2.8157. With a solid ROE of 37.17% and an analyst consensus of 8 Strong Buy ratings, CAH is positioned for further upside.
Cardinal Health Inc (CAH) demonstrates strong financial health with a market cap of $45.72B and a P/E ratio of 29.40, which is reasonable given its revenue growth of 12.88% year-over-year. The company has consistently beaten earnings estimates across the last four quarters, with Q3 2026 earnings at $3.17 per share compared to the estimate of $2.8157. With a solid ROE of 37.17% and an analyst consensus of 8 Strong Buy ratings, CAH is positioned for further upside. Our overall verdict is Bullish.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for CAH at helmterminal.dev/analyze/CAH, updated continuously during US market hours. No signup required.